New Market Report: Prostate Cancer - Pipeline Review, 2015

GlobalData's Medical Devices sector report, "Prostate Cancer - Pipeline Review, 2015" provides an overview of Prostate Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Prostate Cancer diagnostic tests pipeline products.

Full Report Details at
- http://www.fastmr.com/prod/1063412_prostate_cancer_pipeline_2015.aspx?afid=301

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Report Scope

* Extensive coverage of the Prostate Cancer diagnostic tests under development
* The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
* The report reviews the major players involved in the development of Prostate Cancer diagnostic tests and list all their pipeline projects
* The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
* The report provides key clinical trial data of ongoing trials specific to pipeline products
* Recent developments in the segment / industry

Reasons to Get this Report

The report enables you to -

* Formulate significant competitor information, analysis, and insights to improve R&D strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Identify and understand important and diverse types of Prostate Cancer diagnostic tests under development
* Develop market-entry and market expansion strategies
* Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
* In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned in this Report: 3D Biomatrix, LLC, A&G Pharmaceutical, Inc., Abbott Diagnostics, Abnova Corporation, AccuTech, LLC, Advanced Marker Discovery, S.L., Affinimark Technologies, Inc., Almac Diagnostics Limited, AltheaDx, Inc., Ambrilia Biopharma Inc., Andro Diagnostics, Arno Therapeutics, Inc., AroCell AB, Arrayit Diagnostics, Inc., Bayer HealthCare AG, Baylor College of Medicine, Beckman Coulter, Inc., Biocare Medical LLC, Biocept, Inc., Biocrates Life Sciences AG, BioMark Diagnostics Inc., BioMark Technologies Inc., bioMerieux S.A., BioRap Technologies Ltd., Biosceptre (Aust) Pty Ltd, Biotron Limited, Blondin Bioscience, LLC, Caldera Health Limited, Cancer Genetics, Inc., Cancer Research Technology Limited, Caprion Inc., Caris Life Sciences, Inc., Cellanyx Diagnostics, Inc., CellMax Life, Cellmid Limited, Cepheid, Ceres Nanosciences, Inc., ChemImage Corporation, China Sky One Medical, Inc., Chronix Biomedical, Inc., Cleveland Diagnostics Inc., CompanDX Ltd., Courtagen Life Sciences, Inc., CS-Keys, Inc., Cytosystems Ltd, Dartmouth College, Detroit R&D, Inc., Diaxonhit S.A., Egenix, Inc., Epigenomics AG, Euclid Diagnostics LLC, Eventus Diagnostics, Inc., Exiqon A/S, Exosome Diagnostics, Inc., Exosomics Siena SpA, Fluxion Biosciences, Inc., Gene Probe, Inc., GeneFluidics Inc., GeneNews Limited, Genomic Health, Inc., Georgia Institute of Technology, GILUPI Nanomedizin, GlycoZym, Health Discovery Corporation, Hologic, Inc., Ikonisys, Inc., Imperial College London, Inanovate (UK) Ltd., Institut National de la Sante et de la Recherche Medicale, InterGenetics Incorporated, IRIS International, Inc., IV Diagnostics, Inc., KineMed, Inc., MabCure Inc., MacroArray Technologies, LLC., Mayo Clinic, MDNA Life Sciences, Inc., MDxHealth SA, Metabolomic Technologies Inc., Metabolon, Inc., Metanomics Health GmbH, MetaStat, Inc., Milagen, Inc., Minomic International Ltd, Miraculins Inc., Nano Discovery Inc., Neogenix Oncology, Inc., NeoGenomics, Inc., NeuroBioTex Inc., Novel Bio-spectrum Technologies, Inc., NovioGendix Holding B.V, Nuclea Biotechnologies Inc., Numares GmbH, NuView Life Sciences, Inc., Onconome, Inc., ONCOVEDA Cancer Research Center, OncoVista Innovative Therapies, Inc., OPKO Health, Inc., Orion Genomics LLC, Ortho-Clinical Diagnostics Inc., Oryzon Genomics S.A., OTraces Inc., Oxford Gene Technology Limited, Panacea Pharmaceuticals, Inc., PharmaSeq, Inc., Predictive Biosciences, Inc., PrognosDx Health, Inc., Prostate Management Diagnostics, Inc, Protagen AG, Proteocyte Diagnostics Inc, ProteoMediX AG, Proteomika, Proveri Inc., Qiagen N.V., Quanterix Corporation, RiboMed Biotechnologies, Inc., Rice University, Roche Diagnostics International Ltd., Roswell Park Cancer Institute, Siamab Therapeutics, Inc., Siemens Healthcare Diagnostics Inc., Sienna Cancer Diagnostics Ltd, Sividon Diagnostics GmbH, Skuldtech France, Soricimed Biopharma Inc., Source MDx, Stage I Diagnostics, Inc., Target Discovery, Inc., The Johns Hopkins University, Transbiomed, SL, True Diagnostics, Inc., Tyrian Diagnostics Limited, Universite De Lyon, University of California, Los Angeles, University of Central Florida, University of Chicago, University of Colorado, University of Gottingen, University of Oslo, University of Otago, University of Pittsburgh, University of South Australia, University of South Florida, University of Strathclyde, Uppsala County Council, UroSens Ltd, US Biomarkers, Inc., Vermillion, Inc., Vitatex Inc., Vitrimark, Inc., Vitruvian Biomedical, Inc., VolitionRX Ltd., ZEUS Scientific, Inc.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Acquired Gene or Chromosome Alterations - Pipeline Review, 2015
- Pancreatic Cancer - Pipeline Review, 2015
- Ovarian Cancer - Pipeline Review, 2015
- Cervical Cancer - Pipeline Review, 2015
- Abbott Diagnostics - Product Pipeline Analysis, 2015 Update